Insider Buying: ASP Isotopes (NASDAQ:ASPI) Director Buys $40,200.00 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director John Ryan purchased 15,000 shares of the business’s stock in a transaction on Wednesday, September 30th. The stock was purchased at an average cost of $2.68 per share, for a total transaction of $40,200.00. Following the completion of the acquisition, the director directly owned 675,222 shares of the company’s stock, valued at approximately $1,809,594.96. The trade was a 2.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Robert John Andrew Ryan also recently made the following trade(s):

• On Monday, September 28th, John Ryan acquired 8,000 shares of ASP Isotopes stock. The shares were acquired at an average price of $2.70 per share, with a total value of $21,600.00.

ASP Isotopes Stock Up 7.8%

ASP Isotopes stock opened at $2.91 on Friday. ASP Isotopes Inc. has a 1-year low of $2.51 and a 1-year high of $14.49. The business has a fifty day moving average price of $3.70 and a 200-day moving average price of $4.88. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. The stock has a market capitalization of $446.13 million, a price-to-earnings ratio of -2.20 and a beta of 3.69.

ASP Isotopes (NASDAQ:ASPI) last announced its earnings results on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%. The business had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, September 21st. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, ASP Isotopes has an average rating of “Hold” and an average price target of $13.00.

Institutional Trading of ASP Isotopes

Large investors have recently added to or reduced their stakes in the company. Bank of America Corp DE purchased a new position in ASP Isotopes during the 2nd quarter worth approximately $4,410,000. BlackRock Inc. acquired a new stake in ASP Isotopes during the 2nd quarter valued at approximately $57,331,000. Bank of New York Mellon Corp purchased a new stake in shares of ASP Isotopes in the 2nd quarter valued at $2,220,000. Man Group plc purchased a new stake in shares of ASP Isotopes in the 2nd quarter valued at $5,153,000. Finally, AWM Investment Company Inc. acquired a new stake in shares of ASP Isotopes in the second quarter worth $9,837,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.

ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.